Notes - Consolidated Statement Of Comprehensive Income
| Concept | 2024-02-01 to 2025-01-31 | 2023-02-01 to 2024-01-31 | 
|---|---|---|
| Notes - Consolidated statement of comprehensive income | ||
| Notes - Consolidated single statement of comprehensive income | ||
| Notes regarding write-downs of inventories | — | |
| Write-downs of inventories | 
                                                6,857,000
                                                
                                                    
                                                        JPY
                                                    
                                                
                                             | 
                                                4,796,000
                                                
                                                    
                                                        JPY
                                                    
                                                
                                             | 
| Major components of selling, general and administrative expenses | — | |
| Research and development expenses included in general and administrative expenses and manufacturing costs for period | — | |
| Research and development expenses included in general and administrative expenses and manufacturing costs for period | 
                                                911,000
                                                
                                                    
                                                        JPY
                                                    
                                                
                                             | 
                                                1,619,000
                                                
                                                    
                                                        JPY
                                                    
                                                
                                             | 
| Notes regarding impairment losses | — |